HealthTech

Better AI + Correct Provider Guidance = Fewer Denials

Better AI + Correct Provider Guidance = Fewer Denials

Mar 7, 2025 0

How do we tip the scale to lower the rate of denials? While AI has been the init...

CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis

CytomX, Amgen pass on T cell engager; Molecular Partner...

Mar 7, 2025 0

Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T cell eng...

Patient Access and DEI are Not the Same. Why Access Deserves Continued Attention.

Patient Access and DEI are Not the Same. Why Access Des...

Mar 7, 2025 0

Patient access and diversity, equity, and inclusion (DEI) initiatives are not th...

Roche launches new research center with Harvard in Boston area

Roche launches new research center with Harvard in Bost...

Mar 7, 2025 0

Roche announced a new research hub on Friday in partnership with Harvard that it...

Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts

Keys to Provider Patient Communications Amidst Presiden...

Mar 7, 2025 0

Exactly what the administration is ultimately able to accomplish will be anyone’...

Keebler Health Raises $6M to Automate Risk Adjustment for Healthcare Providers in Value-Based Care Environments

Keebler Health Raises $6M to Automate Risk Adjustment f...

Mar 7, 2025 0

AI Platform Proven to Identify 15-30 Percent More Disease Burden by Automating M...

AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch

AVS Completes a $36M Series B Financing Ahead of IVL U....

Mar 7, 2025 0

Amplitude Vascular Systems (AVS), a medical device company focused on safely and...

Making Automation a Mainstream Function in Healthcare Practices

Making Automation a Mainstream Function in Healthcare P...

Mar 7, 2025 0

[Sponsored] In a webinar sponsored by Jotform, scheduled for Thursday, March 13 ...

Tune’s CEO search ends as John McHutchison takes top spot; More from Pfizer’s leadership makeover

Tune’s CEO search ends as John McHutchison takes top sp...

Mar 7, 2025 0

John McHutchison started Monday as CEO and chairman of Tune Therapeutics, after ...

J&J axes Phase 3 depression program due to ‘insufficient efficacy’ shortly after Neumora’s study fail

J&J axes Phase 3 depression program due to ‘insufficien...

Mar 7, 2025 0

Johnson & Johnson scrapped its Phase 3 program for aticaprant, an experimental a...

How Optimizing Administrative Processes Can Transform Patient Access and Health Outcomes

How Optimizing Administrative Processes Can Transform P...

Mar 7, 2025 0

Recently, a global report from the American Journal of Managed Care has ranked t...

6 HIMSS Announcements You Don’t Want to Miss

6 HIMSS Announcements You Don’t Want to Miss

Mar 7, 2025 0

This year’s HIMSS conference featured many news announcements — from advanced pa...

Where Does the Pharmacy Guild Stand in Its Effort to Build a National Pharmacy Union?

Where Does the Pharmacy Guild Stand in Its Effort to Bu...

Mar 7, 2025 0

So far, 13 pharmacies have filed to join the Pharmacy Guild, 11 of which have wo...

First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal

First-in-Class Brain Cancer Drug Strikes a Chord With J...

Mar 7, 2025 0

Jazz Pharmaceuticals’ acquisition of Chimerix brings a drug that could become th...

ModMed Launches AI-Powered Scribe for Dermatology to Transform Clinical Documentation

ModMed Launches AI-Powered Scribe for Dermatology to Tr...

Mar 7, 2025 0

What You Should Know: – ModMed, a provider of specialty-specific healthcare tec...

Withings Analysis Reveals Millions May Be Misclassified as Overweight or Obese

Withings Analysis Reveals Millions May Be Misclassified...

Mar 7, 2025 0

What You Should Know: – Withings, a pioneer in connected health, announced find...

70
71
72
73
74

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.